The latest AVENTICS Series XV release offers greater range with new flow rates, configurations, functionality, certifications ...
According to process control experts, a detailed and specific set of control valve requirements is more than necessary when it comes to good control loop performance.
The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback